T1	Condition 25 39	Postmenopausal
E1	Condition:T1 Name:T24
T2	Eq-Comparison 55 63	>50-year
E2	Eq-Comparison:T2 Operator:T27 Temporal-Unit:T28
T3	Eq-Comparison 73 78	After
E3	Eq-Comparison:T3
T4	Drug 79 88	Denosumab
E4	Drug:T4 Name:T29
T5	Procedure 89 98	treatment
E5	Procedure:T5
T6	Eq-Comparison 99 108	≥ 2 years
E6	Eq-Comparison:T6 Operator:T30 Value:T31 Temporal-Unit:T32
T7	Condition 116 128	osteoporosis
E7	Condition:T7
T8	Condition 164 176	osteoporosis
E8	Condition:T8 Name:T33
T9	Condition 182 204	metabolic bone disease
E9	Condition:T9 Name:T34
T10	Condition 210 216	cancer
E10	Condition:T10 Name:T35
T11	Eq-Comparison 217 224	history
E11	Eq-Comparison:T11 Temporal-Period:T36
T12	Eq-Comparison 230 240	continuous
E12	Eq-Comparison:T12 Temporal-Period:T37
T13	Procedure 241 256	steroid therapy
E13	Procedure:T13 Name:T38
T14	Procedure 262 289	hormone replacement therapy
E14	Procedure:T14 Name:T39
T15	Eq-Comparison 295 299	ever
E15	Eq-Comparison:T15
T16	Other 309 314	other
E16	Other:T16
T17	Procedure 323 348	anti-resorptive treatment
E17	Procedure:T17
T18	Observation 349 387	6.estimated Glomerular filtration rate
E18	Observation:T18 Name:T41
T19	Eq-Comparison 387 398	< 35 mL/min
E19	Eq-Comparison:T19 Operator:T42 Value:T43 Unit:T44 Temporal-Unit:T45
T20	Drug 412 427	Zoledronic acid
E20	Drug:T20 Name:T47
T21	Drug 428 443	8.hypocalcaemia
E21	Drug:T21 Name:T48
T22	Contraindication 450 467	contraindications
E22	Contraindication:T22
T23	Drug 475 490	Zoledronic acid
E23	Drug:T23 Name:T49
T24	Condition-Name 25 39	Postmenopausal
T25	Life-Stage-And-Gender 40 45	women
A1	Life-Stage-And-Gender-Type T25 female
T26	Life-Stage-And-Gender 51 54	Men
A2	Life-Stage-And-Gender-Type T26 male
T27	Eq-Operator 55 56	>
A3	Eq-Operator-Value T27 GT
T28	Eq-Temporal-Unit 56 63	50-year
A4	Eq-Temporal-Unit-Value T28 year
T29	Drug-Name 79 88	Denosumab
T30	Eq-Operator 99 100	≥
A5	Eq-Operator-Value T30 GTEQ
T31	Eq-Value 101 102	2
T32	Eq-Temporal-Unit 103 108	years
A6	Eq-Temporal-Unit-Value T32 year
T33	Condition-Name 164 176	osteoporosis
T34	Condition-Name 182 204	metabolic bone disease
T35	Condition-Name 210 216	cancer
T36	Eq-Temporal-Period 217 224	history
A7	Eq-Temporal-Period-Value T36 past
T37	Eq-Temporal-Period 230 240	continuous
A8	Eq-Temporal-Period-Value T37 present
T38	Procedure-Name 241 256	steroid therapy
T39	Procedure-Name 262 289	hormone replacement therapy
T40	Drug-Name 323 338	anti-resorptive
T41	Observation-Name 349 387	6.estimated Glomerular filtration rate
A9	Observation-Type-Value T41 lab
T42	Eq-Operator 387 388	<
A10	Eq-Operator-Value T42 LT
T43	Eq-Value 389 391	35
T44	Eq-Unit 392 394	mL
T45	Eq-Temporal-Unit 395 398	min
A11	Eq-Temporal-Unit-Value T45 minute
T46	Eq-Unit 399 408	7.allergy
T47	Drug-Name 412 427	Zoledronic acid
T48	Drug-Name 428 443	8.hypocalcaemia
T49	Drug-Name 475 490	Zoledronic acid